MichaelJDetkeMDPhD
Psychiatry • Carmel, INPsychopharmacology
Gereral outpatient part-time at Indiana University School of Medicine (Clinical Associate Professor)
Dr. Detke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5018 Saint Charles Pl
Carmel, IN 46033Phone+1 317-902-2002- Is this information wrong?
Education & Training
Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1996 - 2000
University of PennsylvaniaPhD, Psychology, 1988 - 1998
Perelman School of Medicine at the University of PennsylvaniaClass of 1996
Certifications & Licensure
IN State Medical License 2000 - 2025- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 44 citationsMeasures of outcome for stimulant trials: ACTTION recommendations and research agendaBrian D. Kiluk, Kathleen M. Carroll, Amy M. Duhig, Daniel E. Falk, Kyle M. Kampman, Shengan Lai, Raye Z. Litten, David J. McCann, Ivan D. Montoya, Kenzie L. Preston, P...> ;Drug and Alcohol Dependence. 2016 Jan 1
- 4 citationsComparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety Disorder.Janet B. W. Williams, Kenneth A. Kobak, Earl L. Giller, David S. Reasner, Lisa Curry, Michael J. Detke> ;Journal of Clinical Psychopharmacology. 2015 Dec 1
- 46 citationsA 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophreniaJoan H.Q. Shen, Yonggang Zhao, Sharon Rosenzweig-Lipson, Danielle Popp, Janet B. W. Williams, Earl L. Giller, Michael J. Detke, John M. Kane> ;Journal of Psychiatric Research. 2014 Jun 1
- Join now to see all
Press Mentions
Lighthouse Pharmaceuticals Announces Progression of LHP588 Clinical Development Program in Alzheimer's DiseaseMay 10th, 2023- Cortexyme Provides New GAIN Trial Data at AD/PD 2022 Demonstrating Potential Benefit of Lysine Gingipain Inhibition in Mild to Moderate Alzheimer’s PopulationMarch 21st, 2022
- Cortexyme, SQZ, Others Present New Insights into Alzheimer's and Parkinson'sMarch 21st, 2022
- Join now to see all
Hospital Affiliations
Indiana University Health University HospitalIndianapolis, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
